Results 241 to 250 of about 157,233 (348)
Romosozumab and Denosumab Combination Therapy After Denosumab in Postmenopausal Osteoporosis
Background Transition from long‐term denosumab to PTH‐analogs or romosozumab might expose patients to the risk of the so‐called rebound phenomenon. Adding romosozumab to denosumab might represent an option in patients experiencing a fracture while on denosumab.
Giovanni Adami +10 more
wiley +1 more source
Full mouth rehabilitation with Implant-Guided Surgery and Fixed prosthesis
Seong-Mo Kim +4 more
openalex +1 more source
Full Mouth Rehabilitation in Dental Fluorosis Patient - A Time Restrained Scenario
Saloni Kachhara, Ashok Vaseashta
openalex +1 more source
Objectives Femoroacetabular impingement (FAI) and synovitis have been recognized as essential factors for developing osteoarthritis (OA) in the hip joints. However, little is known about altered synovial cellular compositions, their associated transcriptomic profiles, and cell‐cell interactions in FAI and hip OA.
Gulzada Kulzhanova +9 more
wiley +1 more source
Full Mouth Rehabilitation With All-on-Six Concept With Computer-Aided Design/Computer-Aided Manufacturing (CAD/CAM) Milled Bar Retained Zirconia Prosthesis. [PDF]
Beri A +5 more
europepmc +1 more source
Objective The multinational, phase 3, double‐blind, placebo‐controlled TULIP‐SC trial evaluated the efficacy and safety of subcutaneous anifrolumab in adults who have moderate‐to‐severe SLE activity, despite receiving standard therapy. Methods Adults with SLE received subcutaneous anifrolumab 120 mg or placebo once weekly for 52 weeks (1:1 ...
Susan Manzi +12 more
wiley +1 more source
Evaluation of Changes in Oral Microflora in Children with Early Childhood Caries after Full Mouth Rehabilitation. [PDF]
Mathew MG, Jeevanandan G, Rathod NN.
europepmc +1 more source
Commentary: Three questions for the study of traumatic brain injury in animals
The Anatomical Record, EarlyView.
Gregory Hollin
wiley +1 more source

